This week's roundup of Houston innovators includes Adrianne Stone of Bayou City Startups, Sarma Velamuri of Luminare, and Curtis Jackson of G-Unity Foundation. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from health tech to nonprofit — recently making headlines in Houston innovation.

Adrianne Stone, founder of Bayou City Startups

Every month, Adrianne Stone of Bayou City Startups hosts a happy hour for startup founders to create a safe space to network, collaborate, commensurate, and more. Photo courtesy of Adrianne Stone

Adrianne Stone knows firsthand how lonely the startup founder journey is, so she set out to help create a community for founders when she started Bayou City Startups last year. Now, Stone shares on the Houston Innovators Podcast that her monthly happy hours attract over 50 attendees on average.

"Being the venture associate with Capital Factory in Houston, I'd seen what the Houston ecosystem had to offer. There were events — happy hours, coffee meet-ups, all these things," Stone says on the show. "But it was not just a casual networking event usually. I wanted a consistent community where I could show up and say, 'guys, I had the worst week,' to people who got where I was coming from and who could commensurate or lean in and help."

The next opportunity to network with Bayou City Startups is Tuesday, July 18, from 5 to 7 pm at Kirby Ice House. Read more.

Sarma Velamuri, co-founder and CEO of Luminare

Sepsis has been the No. 1 killer hospitals, but this Houston startup has a tech to help mitigate the risk. Photo via Getty Images

When he was an internal medicine physician, Sarma Velamuri watched helplessly as a friend’s 22-year-old daughter lost her life to sepsis. He had to tell his friend that she would not be coming home.

“There are 300,000-plus people a year who die of sepsis,” says Velamuri. “It’s important that people understand it’s not just those who are most susceptible to infections.”

This fact is not only unfortunate, but preventable. And that’s why Velamuri, who describes himself as “a recovering hospitalist,” co-founded Luminare in 2014. A full-time CEO since 2017, Velamuri, who runs the company with co-founder and CTO Marcus Rydberg, is based in the TMC Innovation Factory. Read more.

Curtis Jackson, founder of the G-Unity Foundation

For the second year, Curtis Jackson's program supported Houston student entrepreneurs. Photo courtesy of G-Unity

Chances are, you've heard of 50 Cent — his 2003 album "Get Rich or Die Tryin'" was a soundtrack to many. But Curtis James Jackson III, 50 Cent's real name, has done a lot since gracing your radios. He moved to Houston in 2021 and founded the G-Unity Foundation. In May, he wrapped on the second year of the G-Unity Business Labs, a business development incubator for Houston Independent School District high schoolers.

"I’ve spent years donating my time and energy to communities in need. I started G-Unity to do the same—to give back to kids so they have it a little easier than I did," Jackson writes on the website. "Team building and entrepreneurship are skills I learned along the way, but they are so important to develop early. I look forward to G-Unity supporting programs that are doing the crucial work of teaching kids to excel at life."

Around 150 students participated, and the winners are splitting a $500,000 investment. Read more.

Sepsis has been the No. 1 killer hospitals, but this Houston startup has a tech to help mitigate the risk. Photo via Getty Images

Houston startup taps into AI to help prevent leading cause in hospital death

coming for sepsis

Anyone can die of sepsis. The number one killer in hospitals has a reputation for felling the infirm and elderly, but while the immunocompromised are at highest risk, sepsis isn’t that selective.

Take 12-year-old Rory Staunton. In 2012, the healthy boy scratched his arm diving for a ball in gym class at his school in Jackson Heights, NY. Bacteria entered his arm through the cut and he died days later of septic shock.

His story is not unique. Physician Sarma Velamuri saw this firsthand in his internal medicine practice at St. Luke’s Health Center and his residency at Baylor, both in Houston. But it really struck home when he watched helplessly as a friend’s 22-year-old daughter lost her life to sepsis. He had to tell his friend that she would not be coming home.

“There are 300,000-plus people a year who die of sepsis,” says Velamuri. “It’s important that people understand it’s not just those who are most susceptible to infections.”

This fact is not only unfortunate, but preventable. And that’s why Velamuri, who describes himself as “a recovering hospitalist,” co-founded Luminare in 2014. A full-time CEO since 2017, Velamuri, who runs the company with co-founder and CTO Marcus Rydberg, is based in the TMC Innovation Factory.

“Because of the complex workflows in hospitals, sometimes it takes 10 people to get the patient the care they need,” Velamuri explains.

And because of the pervasiveness of sepsis, it’s important to screen every patient who enters an institution before it gets to that point.

Luminare’s technology allows nurses, who are notoriously spread thin, to automatically screen patients in 10 seconds using 50 different parameters.

“We’re looking at a vast amount of data simultaneously,” says Velamuri. “We’re not generating any new data, we’re taking data that exists and shining a light on it.”

In 2020, the technology found a new application when Velamuri and his team created a version of Luminare that helped with the hospital workflow surrounding COVID PCR testing and vaccine management. Since then, it has also been used to help identify and treat monkeypox.

Though Velamuri says he doesn’t want to distract Luminare from its goal of making sepsis the number-two killer in hospitals, he is also aware that his technology can be instrumental in identifying and treating patients at risk for countless other maladies, including heart failure and stroke, and even helping with oncology workflows.

Velamuri says that his team is Luminare’s biggest strength, far more than the AI that they have designed.

“I have this saying that AI is a great servant but a terrible master. It doesn’t solve the problem,” says Velamuri.

Though the company is distributed as far afield as Stockholm, about half of its people live and work in Houston. Of the company’s placement in TMC’s Innovation Factory, Velamuri says, “They’ve been tremendous partners to us. The company would not be as successful today without their supportive partnership.” Not least of that is working with in the same space as other founders who can share their expertise as easily as a trip to the coffee machine.

And the company is growing quickly. Last year, Luminare participated in Cedars-Sinai’s accelerator program. Thanks to that partnership, the hospital is now using Luminare’s technology for sepsis screening. The team is working to partner with even more large hospital systems on solutions for one of the health industry’s biggest problems. And data that shows that Luminare can be the path to preventing death from hospitals’ most prolific killer.

Sarma Velamuri went from MD to CEO when he founded Luminare. Photo via luminare.io

This week's roundup of Houston innovators includes Deanna Zhang of Tudor, Pickering, & Holt Co., Sarma Velamuri of Luminare, and Amy Chronis of Deloitte. Courtesy photos

3 Houston innovators to know this week

who's who

Editor's note: In the week's roundup of Houston innovators to know, I'm introducing you to three innovators recently making headlines — from health tech founders to the new GHP chair.

Deeana Zhang, director of energy technology at Tudor, Pickering, Holt & Co.

Deanna Zhang of Tudor, Pickering, Holt & Co. joined the Houston Innovators Podcast to discuss 2020's effect on the energy transition — and what that meant for startups. Photo courtesy of TPH

Deanna Zhang looks closely at the energy innovation market and, well, last year was extremely enlightening about the energy industry and where tech is taking it. She joined the Houston Innovators Podcast last week to discuss some of the 2020 trends and observations she had — and what that means for 2021.

"The energy transition saw a huge uptick in 2020 — and there's a lot of implications of that from what pilots are getting commercialized and what companies are getting more funding," says Zhang. "All around it was hugely disruptive — but hugely beneficial I think to the energy transition." Click here to read more and stream the episode.

Dr. Sarma Velamuri, CEO of Luminare

A Houston health tech startup has launched a COVID-19 vaccine management tool. Image via luminaremed.com

As great as it was to be able to begin distributing the life-saving COVID-19 vaccine, the logistics of the two-dose process was a nightmare. Dr. Sarma Velamuri, CEO of Luminare, thought he could innovate a solution. His new platform, Innoculate (a mash-up of "innovate" and "inoculate"), enables organizations like public health departments, fire departments, school systems, and businesses to manage high-volume vaccination initiatives.

"Usually when you hear news of a new batch of vaccines headed your way, there is dread at the management and distribution overhead. Not anymore," Velamuri says in a release. "Innoculate will help streamline the vaccination process in the fight against COVID-19 and allow for hundreds of thousands of people to get vaccines easily." Click here to read more.

Amy Chronis, Greater Houston Partnership's 2021 chair and the Houston managing partner at Deloitte

Houston, we have a perception problem — but the Greater Houston Partnership's new chair, Amy Chronis, is here to fix it. Photo courtesy Deloitte/AlexandersPortraits.com

Hey Houston, it's time to speak up — a little louder for the people in the back. That's what Amy Chonis, 2021 chair for the Greater Houston Partnership, wants you to know, and that it's important for business leaders across the city to take the initiative about how great Houston is.

"We just don't brag enough about how much the city has changed and its trajectory," she tells InnovationMap.

While Houston has long been innovative in the health, space, and energy industries, it has a perception problem. Recently, Chronis addressed some of these concerns in her address at the GHP's 2021 Annual Meeting. She joined InnovationMap for an interview to zero in on how the business community can work to change this perception problem and continue to grow its innovation and tech community. Click here to read the Q&A.

Image via luminaremed.com

Houston health tech startup launches COVID-19 vaccine management tool

inoculation innovation

Houston-based health care software startup Luminare Inc. is arming soldiers in the coronavirus vaccination campaign with technology to help smooth the inoculation process.

Luminare, which launched with the mission of combating sepsis, switched gears after the onset of the coronavirus pandemic to help combat the virus' spread. One of the ways it's doing that is with Innoculate (a mash-up of "innovate" and "inoculate"). The new platform enables organizations like public health departments, fire departments, school systems, and businesses to manage high-volume vaccination initiatives.

Among other benefits, Innoculate automates vaccination sign-ups and scheduling, tracks the number of vaccine batches available, flags previous allergic reactions among vaccine recipients, and helps achieve compliance with federal, state and local health care requirements.

"Usually when you hear news of a new batch of vaccines headed your way, there is dread at the management and distribution overhead. Not anymore," Dr. Sarma Velamuri, CEO of Luminare, says in a release. "Innoculate will help streamline the vaccination process in the fight against COVID-19 and allow for hundreds of thousands of people to get vaccines easily."

One of the first customers of Innoculate is the Corpus Christi-Nueces County Public Health District. Innoculate helped the district vaccinate 9,000 people during the first week of its vaccination effort. Peter Collins, chief information officer of the City of Corpus Christi, says Innoculate allows more vaccinations to be done without adding administrative burdens.

Corpus Christi-Nueces County Public Health District was the first government outfit to use Innoculate. The district also uses Luminare's Quickscreen COVID-19 screening and testing tool.

Dallas County Health and Human Services also is adopting Innoculate. On January 27, Dallas County approved a 12-month contract with Luminare worth up to $601,500.

Other new customers that are lined up for Innoculate include the Abilene-Taylor County Public Health District, Wichita Falls-Wichita County Public Health District, and Brenham-based Blinn College District. Innoculate deals are being finalized with 13 other city and county governments.

Luminare says it wants to "help as many cities and counties in the U.S. that we can." The company asks organizations seeking help with coronavirus vaccination campaigns to email mike.gilbert@luminaremed.com or info@luminaremed.com.

Luminare was founded in 2014 with the goal of preventing sepsis, a life-threatening reaction to a host of infections that triggers about one-third of U.S. hospital deaths. Its sepsis-targeted software is called Sagitta.

After the coronavirus began spreading, Luminare tweaked its sepsis-detection platform, called Quickscreen, to produce a free online self-assessment for people who suspect they've been infected with the virus. The startup was honored for this work as COVID Phoenix in Houston Exponential's inaugural awards program, The Listies. Now, it has added Innoculate to its pandemic-fighting arsenal.

Luminare, based at Texas Medical Center's innovation campus, is a 2018 graduate of the TMCx accelerator. According to Crunchbase, the company has collected more than $1.6 million in funding.

Here's who won big for Houston innovation. Photos courtesy

Houston Exponential names winners of inaugural innovation awards

And the winner is...

In a virtual awards program, Houston Exponential has revealed the winners of the inaugural Listies awards.

The Listies, brought to you by Houston Exponential in partnership with InnovationMap, named the winning companies and people across 12 awards on November 20 at 3 pm as a part of Impact Hub's annual The Houston Innovation Summit (THIS).

Nominations were open until Friday, November 6, and then a group of judges made up of members of the Houston innovation ecosystem reviewed the submissions to settle on the 38 finalists. Click here to see the finalists.

Here's who took home the big wins.

SDO Superstar: MassChallenge Texas

Photo courtesy of MassChallenge

A startup development organization can be an accelerator program, an incubator, or a coworking space — and organizations falling into all three of these sectors were nominated for this category. MassChallenge Texas, which has been running its non-equity, general accelerator program in Houston for two years, stood out to judges to take the win for the SDO Superstar category.

Individual Contributor: Slawek Omylski of SecurityGate

Photo via LinkedIn

The individual contributor award was meant to find and recognize a non-founder who was essential to the success of a Houston startup, and that's exactly how SecurityGate's team sees Slawek Omylski, director of engineering. Not only has he been essential from the start over three years ago when he joined as employee No. 4, but Omylski, when unexpectedly having to move back home to Italy, never missed a single meeting or tech deployment despite being an ocean away from the rest of his team. Known as "Suave" by his teammates, his nominators say Omylski is usually the first to arrive at the office and the last to leave.

Civic Innovation: Annapurna Solutions

Image viaannapurnasolutions.org

Everyone knows that the key to sustainability is reducing, reusing, and recycling, but the fact of the matter is no one has quite perfected recycling. Houston-based Annapurna Solutions is stepping in to help. The company provides innovative technology solutions to address waste and recycling challenges, helping to make cities smart and sustainable — like the company's ReciklApp.

Welcome to Houston: Greentown Labs

Photo via greentownlabs.com

Greentown Labs is a startup development organization, but it's are also a startup itself, but when it opens its doors in Houston in the spring, the organization isn't starting from scratch. After years of working with over 200 climatech companies in the Boston area, Greentown's expansion into Houston means incubating Houston energy tech companies and furthering the conversation and activation within the energy transition.

Investor of the Year: Integr8d Capital

Photo via TMC.edu

John "J.R." Reale has been a well respected mentor, entrepreneur, and investor in Houston for years. His firm Integr8d Capital has invested in several Houston companies, including Liongard from seed stage to series A and series B. Reale is also the entrepreneur in residence for the TMC Innovation Institute.

Corporate Innovator: Houston Methodist

Courtesy of Methodist Hospital/Facebook

Houston Methodist and its Center for Innovation led by Roberta Schwartz is leading health tech innovation in Houston. In January, the hospital opened its Technology Hub, 3,500-square-foot space renovated from a former 18-room patient wing to showcase and test new digital health technologies like virtual reality, ambient listening, wearables, and more. Additionally, the hub helped with the training of dozens of doctors with the rise of telemedicine during COVID-19.

Outstanding Leadership: Grace Rodriguez

Photo courtesy of Grace Rodriguez

Grace Rodriguez's career spans industry and time, but her leadership has been consistent throughout. She currently serves Impact Hub Houston as CEO and executive director. Her nominator calls her an inspiration and someone who "shows up," clearly loving everything she does and is responsible. During COVID-19, she's gone above and beyond to provide resources and information to everyone who needs it, including launching a fund to help pay for meals for health care workers and first responders. The LIFE Fund raised over $20,000.

COVID Phoenix: Luminare

Image via luminaremed.com

Originally founded by Dr. Sarma Velamuri to treat and fight sepsis, Luminare took its sepsis platform and pivoted it to created a COVID self-assessment and testing tool. Their digital platform directed 5.5 million people to COVID-19 testing sites in just 21 days, according to its nomination. The tool was used by Harris County and several other entities.

DEI Champion: Maria Maso

Photo courtesy of Nijalon Dunn

Maria Maso is looking out for minorities when it comes to investment. As the founder and CEO of the Business Angel Minority Association (baMa) — an Angel Association aimed at bridging minority-founded startups with accesses to capital — Maria has been a champion for diversity. She also has helped to educate and activate 40 diverse investors through baMa's Diversity Investor Academy, according to her nomination.

Mentor of the Year: Landi Spearman

Photo via LinkedIn

Landi Spearman's approach to mentorship, according to her nominee, is to mentor the full person — from professional to personal life — through Organized SHIFT, which focuses on helping highly productive leaders, individuals and organizations in their quest to sustain positive growth internally and externally. She also supports entrepreneurs though The Ion, Station Houston, General Assembly, the National Urban League, Power to Fly, Black Women in Science and Engineering, the Greater Houston Partnership, the Greater Houston Black Chamber, Pink Petro, and more.

People's Choice and Soonicorn: Liongard

Photos via LinkedIn

People's Choice was based off how many nominations the startups received, and Liongard was a clear winner. The company, which also won in the Soonicorn category, has experienced major growth and, as the nominations read, that's to both Joe Alapat and Vincent Tran, co-founders, credit. The company has raised $12 million to date — the most recent round, a $10 million Series A — closed this year.

Houston Exponential has announced the 38 finalists for the inaugural Listies Awards. Photo via Getty Images

Exclusive: HX names finalists for inaugural Houston innovation awards

the listies go to...

Ever wonder what Houston startups and innovators are the best of the best? Here's your chance to figure it out. The inaugural Listies awards program has named its finalists.

The Listies, brought to you by Houston Exponential in partnership with InnovationMap, will name the winning companies and people across 12 awards on November 20 at 3 pm at a virtual event as a part of Impact Hub's annual The Houston Innovation Summit (THIS). Click here to register for the free event.

Nominations were open until Friday, November 6, and then a group of judges made up of members of the Houston innovation ecosystem reviewed the submissions to settle on the finalists. Below, in alphabetical order, the 38 finalists are listed for each category.

DEI champion

  • Heath Butler
  • Maria Maso
  • Grace Rodriguez

Individual contributor

  • Michael Matthews
  • Slawek Omylski
  • Brad True

Mentor of the year

  • Keith Kreuer
  • Wade Pinder
  • Landi Spearman

Outstanding leadership

  • Stephanie Campbell
  • Grace Rodriguez
  • Roberta Schwartz

Corporate innovation

  • Chevron Technology Ventures
  • Houston Methodist
  • Shell Ventures

Investor of the year

  • CSL Capital Management
  • Golden Section VC (GSTVC)
  • Integr8d Capital

SDO superstar

  • MassChallenge Houston
  • Rice Alliance
  • TMCx

Welcome to Houston

  • Greentown Labs
  • TestCard
  • Win-Win

Civic engagement

  • Annapurna
  • Luminare
  • McMac Cx

COVID pivot/phoenix

  • Luminare
  • re:3D
  • sEATz

People choice

  • INK
  • Liongard
  • Luminare
  • re:3D
  • Topl

Soonicorn

  • GoExpedi
  • Liongard
  • Medical Informatics Corp.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston space org to launch experiments aboard first mission into polar orbit

all aboard

Houston's Translational Research Institute for Space Health, or TRISH, will send its latest experiments into space aboard the Fram2 mission, the first all-civilian human spaceflight mission to launch over the Earth’s polar regions.

Fram2, operated by SpaceX, is targeting to launch Monday, March 31, at NASA’s Kennedy Space Center in Florida. The crew of four is expected to spend several days in polar orbit aboard the SpaceX Dragon spacecraft in low Earth orbit. TRISH’s research projects are among 22 experiments that the crew will conduct onboard.

The crew's findings will add to TRISH's Enhancing eXploration Platforms and ANalog Definition, or EXPAND, program and will be used to help enhance human health and performance during spaceflight missions, including missions to the moon and Mars, according to a release from TRISH.

“The valuable space health data that will be captured during Fram2 will advance our understanding of how humans respond and adapt to the stressors of space,” Jimmy Wu, TRISH deputy director and chief engineer and assistant professor in Baylor’s Center for Space Medicine, said in the release. “Thanks to the continued interest in furthering space health by commercial space crews, each human health research project sent into orbit brings us closer to improving crew member well-being aboard future spaceflight missions.”

The six TRISH projects on Fram2 include:

  • Cognitive and Physiologic Responses in Commercial Space Crew on Short-Duration Missions, led by Dr. Mathias Basner at the University of Pennsylvania Perelman School of Medicine. The crew will wear a Garmin smartwatch and a BioIntelliSense BioButton® medical grade device to track cognitive performance, including memory, spatial orientation, and attention before, during, and after the mission.
  • Otolith and Posture Evaluation II, led by Mark Shelhamer at Johns Hopkins University. The experiment will look at how astronauts’ eyes sense and respond to motion before and after spaceflight to better understand motion sickness in space.
  • REM and CAD Radiation Monitoring for Private Astronaut Spaceflight, led by Stuart George at NASA Johnson Space Center. This experiment will test space radiation exposure over the Earth’s north and south poles and how this impacts crew members.
  • Space Omics + BioBank, led by Richard Gibbs and Harsha Doddapaneni at Baylor College of Medicine. The experiment will use Baylor’s Human Genome Sequencing Center's Genomic Evaluation of Space Travel and Research program to gain insights from pre-flight and post-flight samples from astronauts.
  • Standardized research questionnaires, led by TRISH. The test asks a set of standardized research questionnaires for the crew to collect data on their sleep, personality, health history, team dynamics and immune-related symptoms.
  • Sensorimotor adaptation, led by TRISH. The project collects data before and after flight to understand sensorimotor abilities, change and recovery time to inform future missions to the moon.

TRISH, which is part of BCM’s Center for Space Medicine with partners Caltech and MIT, has launched experiments on numerous space missions to date, including Blue Origin's New Shepard rocket last November and Axiom Space's Ax-3 mission to the International Space Station last January.

Houston lab develops AI tool to improve neurodevelopmental diagnoses

developing news

One of the hardest parts of any medical condition is waiting for answers. Speeding up an accurate diagnosis can be a doctor’s greatest mercy to a family. A team at Baylor College of Medicine has created technology that may do exactly that.

Led by Dr. Ryan S. Dhindsa, assistant professor of pathology and immunology at Baylor and principal investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, the scientists have developed an artificial intelligence-based approach that will help doctors to identify genes tied to neurodevelopmental disorders. Their research was recently published the American Journal of Human Genetics.

According to its website, Dhindsa Lab uses “human genomics, human stem cell models, and computational biology to advance precision medicine.” The diagnoses that stem from the new computational tool could include specific types of autism spectrum disorder, epilepsy and developmental delay, disorders that often don’t come with a genetic diagnosis.

“Although researchers have made major strides identifying different genes associated with neurodevelopmental disorders, many patients with these conditions still do not receive a genetic diagnosis, indicating that there are many more genes waiting to be discovered,” Dhindsa said in a news release.

Typically, scientists must sequence the genes of many people with a diagnosis, as well as people not affected by the disorder, to find new genes associated with a particular disease or disorder. That takes time, money, and a little bit of luck. AI minimizes the need for all three, explains Dhindsa: “We used AI to find patterns among genes already linked to neurodevelopmental diseases and predict additional genes that might also be involved in these disorders.”

The models, made using patterns expressed at the single-cell level, are augmented with north of 300 additional biological features, including data on how intolerant genes are to mutations, whether they interact with other known disease-associated genes, and their functional roles in different biological pathways.

Dhindsa says that these models have exceptionally high predictive value.

“Top-ranked genes were up to two-fold or six-fold, depending on the mode of inheritance, more enriched for high-confidence neurodevelopmental disorder risk genes compared to genic intolerance metrics alone,” he said in the release. “Additionally, some top-ranking genes were 45 to 500 times more likely to be supported by the literature than lower-ranking genes.”

That means that the models may actually validate genes that haven’t yet been proven to be involved in neurodevelopmental conditions. Gene discovery done with the help of AI could possibly become the new normal for families seeking answers beyond umbrella terms like “autism spectrum disorder.”

“We hope that our models will accelerate gene discovery and patient diagnoses, and future studies will assess this possibility,” Dhindsa added.

Texas robotics co. begins new search for missing Malaysia Airlines flight 370

International News

Malaysia’s government has given final approval for a Texas-based marine robotics company to renew the search for Malaysia Airlines Flight 370, which is believed to have crashed in the southern Indian Ocean more than a decade ago.

Cabinet ministers agreed to terms and conditions for a “no-find, no-fee” contract with Texas-based Ocean Infinity to resume the seabed search operation at a new 5,800-square-mile site in the ocean, Transport Minister Anthony Loke said in a statement Wednesday. Ocean Infinity will be paid $70 million only if wreckage is discovered.

The Boeing 777 plane vanished from radar shortly after taking off on March 8, 2014, carrying 239 people, mostly Chinese nationals, on a flight from Malaysia’s capital, Kuala Lumpur, to Beijing. Satellite data showed the plane turned from its flight path and headed south to the far-southern Indian Ocean, where it is believed to have crashed.

An expensive multinational search failed to turn up any clues to its location, although debris washed ashore on the east African coast and Indian Ocean islands. A private search in 2018 by Ocean Infinity also found nothing.

The final approval for a new search came three months after Malaysia gave the nod in principle to plans for a fresh search.

Ocean Infinity CEO Oliver Punkett earlier this year reportedly said the company had improved its technology since 2018. He has said the firm is working with many experts to analyze data and had narrowed the search area to the most likely site.

Loke said his ministry will ink a contract with Ocean Infinity soon but didn’t provide details on the terms. The firm has reportedly sent a search vessel to the site and indicated that January-April is the best period for the search.

“The government is committed to continuing the search operation and providing closure for the families of the passengers of flight MH370,” he said in a statement.